(1 - 20 von 23
)
faCellitate appoints Christoph Petry, Ph.D. to become Managing …
www.news-blast.com
Web30. Nov · faCellitate GmbH has appointed Dr. Christoph Petry, as Managing Director and CEO. Dr. Petry spun-out Sividon Diagnostics from Siemens Healthcare in …
FIDURA Private Equity Funds: Successful sale of portfolio company...
www.news-research.net
· Marco Winzer, Partner of High-Tech Gründerfonds and Dr. Christoph Petry, CEO of m2p-labs GmbH, add: "Our consortium of investors was for many years an excellent financial partner and sparring partner for the m2p team.
Myriad Genetics and Sividon Diagnostics Announce Exclusive Co ...www.eqs-news.com › news › corporate › myriad-ge...
www.eqs-news.com
· ... capability and coverage in many key countries creates an outstanding partnership,' said Dr. Christoph Petry, CEO of Sividon Diagnostics.
Myriad acquires Sividon DiagnosticsDrug Discovery News
www.drugdiscoverynews.com
— ... excited to be integrated with the global leader and pioneer in personalized medicine,” said Christoph Petry, CEO of Sividon Diagnostics. › ...
sortiert nach Relevanz / Datum